Frontiers
US$ 26.30
taking tirzepatide Why Am I Not Losing
Description
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, distinguishing it from currently approved weight management agents
You will need to submit a valid prescription for Zepbound for its FDA-approved use
The primary concerns revolve around potential overlapping gastrointestinal side effects such as nausea, vomiting, diarrhea, or constipation, which both medications can cause
Oncol Lett 11:25152519
Gastrointestinal Malabsorption of Thyroxine
One study involved 751 people split into two groups: one taking tirzepatide and the other taking semaglutide for 72 weeks
